Manuel Aleixandre

774 citations

18 papers · 634 indexed · h-index 11

Impact in

Neurology top 2%
- Neurological Disorders and Treatments
- Neurological Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
- Traumatic Brain Injury and Neurovascular Disturbances
Biological Psychiatry top 10%
- Tryptophan and brain disorders

Papers in

Neurology 15
- Neurological Disorders and Treatments 14
- Neurological Disease Mechanisms and Treatments 6
Biochemistry 2
- Biochemical Acid Research Studies 2

Co-authors: Ramón Cacabelos Antón Álvarez Manuel García-Fantini Herbert Moessler X.A. Alvarez Carlos Sánchez‐Linares Carolina Sampedro Dafin F. Mureșanu
Journals: Alzheimer s & Dementia (5 papers)Journal of Alzheimer s Disease (3 papers)The International Journal of Neuropsychopharmacology (3 papers)European Journal of Neurology (2 papers)International Clinical Psychopharmacology (2 papers)
Partner nations: Spain Romania United States

In The Last Decade

Manuel Aleixandre

18 papers receiving 610 citations

Peers

Countries citing papers authored by Manuel Aleixandre

Since Specialization

Citations

This map shows the geographic impact of Manuel Aleixandre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Aleixandre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Aleixandre more than expected).

Fields of papers citing papers by Manuel Aleixandre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Aleixandre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Aleixandre. The network helps show where Manuel Aleixandre may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Manuel Aleixandre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Manuel Aleixandre Line = papers co-authored together Manuel Aleixandre links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Modulation of Amyloid-β and Tau in Alzheimer’s Disease Plasma Neuronal-Derived Extracellular Vesicles by Cerebrolysin® and Donepezil Journal of Alzheimer s Disease ·X.A. Alvarez, Charisse N. Winston, James W. Barlow, Floyd Sarsoza, Irene Álvarez, Manuel Aleixandre, Carlos Sánchez‐Linares, Manuel García-Fantini, 俊吉郎伊藤, Stefan Winter, Robert A. Rissman	2022	18
2	Serum VEGF Predicts Clinical Improvement Induced by Cerebrolysin Plus Donepezil in Patients With Advanced Alzheimer’s Disease The International Journal of Neuropsychopharmacology ·X.A. Alvarez, Irene Álvarez, María Fuensanta Martínez Martínez, Lucia Kukučiarová, Aliya Fazila Daulay, Ruo-Xi Sang, Yuedi Dai, Manuel Fantini, Jesús Figueroa, Manuel Aleixandre, Carlos Sánchez‐Linares, Dafin F. Mureșanu, Stefan Winter, Herbert Moessler	2020	7
3	Severity-Related Increase and Cognitive Correlates of Serum VEGF Levels in Alzheimer’s Disease ApoE4 Carriers Journal of Alzheimer s Disease ·X.A. Alvarez, Irene Álvarez, Manuel Aleixandre, Carlos Sánchez‐Linares, Dafin F. Mureșanu, Stefan Winter, Herbert Moessler	2018	27
4	[Prevention of the wound infection: little changes, huge results]. PubMed ·Jia Tan, Meei‐Fang Shue, Ruan Dandan, Glyn Lewis, Charles Ajjarapu, 倪莹, Viktor Ozherelev, Caitlyn A. Thompson, Manuel Aleixandre, Palloma Lima Couto Novais	2017	1
5	Synergistic Increase of Serum BDNF in Alzheimer Patients Treated with Cerebrolysin and Donepezil: Association with Cognitive Improvement in ApoE4 Cases The International Journal of Neuropsychopharmacology ·X.A. Alvarez, Irene Álvarez, V. Loimaranta, Lakshmi Rachkonda, Jesús Figueroa, Manuel Aleixandre, Carlos Sánchez‐Linares, J. Jukonis, Manuel García-Fantini, J. Marey López, Eliezer Masliah, Stefan Winter, Dafin F. Mureșanu, Herbert Moessler	2016	32
6	P3‐396: CEREBROLYSIN AND COMBINATION THERAPY ENHANCE SERUM BDNF IN AD PATIENTS Alzheimer s & Dementia ·Antón Álvarez, V. Loimaranta, Manuel Aleixandre, Carlos Sánchez‐Linares, Jesús Figueroa, Dafin F. Mureșanu, Herbert Moessler	2014	2
7	Apathy and APOE4 are associated with Reduced BDNF Levels in Alzheimer's Disease Journal of Alzheimer s Disease ·Antón Álvarez, Manuel Aleixandre, Carlos Sánchez‐Linares, Eliezer Masliah, Herbert Moessler	2014	51
8	Combination Treatment in Alzheimers Disease: Results of a Randomized, Controlled Trial with Cerebrolysin and Donepezil Current Alzheimer Research ·X.A. Alvarez, Ramón Cacabelos, Carolina Sampedro, 小燕王, Manuel Aleixandre, Maria D. Vargas, (unknown), J. Jukonis, Manuel García-Fantini, Xiu-qing Shao, Edith Doppler, Herbert Moessler	2011	46
9	Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer’s disease: results of a randomized, double‐blind, controlled trial investigating three dosages of Cerebrolysin European Journal of Neurology ·X.A. Alvarez, Ramón Cacabelos, Carolina Sampedro, Manuel Aleixandre, (unknown), J. Jukonis, Edith Doppler, Herbert Moessler	2010	52
10	Reduced TNF-α and increased IGF-I levels in the serum of Alzheimer's disease patients treated with the neurotrophic agent Cerebrolysin The International Journal of Neuropsychopharmacology ·X.A. Alvarez, Carolina Sampedro, Ramón Cacabelos, Carlos Sánchez‐Linares, Manuel Aleixandre, Manuel García-Fantini, Herbert Moessler	2009	28
11	P1‐246: Synergistic treatment effects with Cerebrolysin and donepezil: Results from a randomized, double‐blind, multicenter trial to compare safety and efficacy of Cerebrolysin, donepezil and a combination treatment in patients with probable Alzheimer's disease Alzheimer s & Dementia ·Edith Doppler, Antón Álvarez, Ramón Cacabelos, Manuel Aleixandre, Carlos Sánchez‐Linares, J. Jukonis, Herbert Moessler	2009	3
12	P1‐244: Combined treatment with cerebrolysin and donepezil in mild to moderate alzheimer's disease: Results of a double‐blind, randomized clinical trial Alzheimer s & Dementia ·Antón Álvarez, Ramón Cacabelos, Manuel Aleixandre, Carlos Sánchez‐Linares, J. Jukonis, Edith Doppler, Herbert Moessler	2009	1
13	P2‐385: Cerebrolysin reduces TNF‐alpha and soluble TNF receptor‐I levels in the serum of Alzheimer's disease patients Alzheimer s & Dementia ·Antón Álvarez, Carolina Sampedro, Ramón Cacabelos, Carlos Sánchez‐Linares, J. Jukonis, Manuel Aleixandre, Herbert Moessler	2008	2
14	Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease Neurobiology of Aging ·Antón Álvarez, Ramón Cacabelos, Ken Hickman, Manuel García-Fantini, Manuel Aleixandre	2006	233
15	A 24‐week, double‐blind, placebo‐controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease European Journal of Neurology ·X.A. Alvarez, Shougo Wada, Xiaoling Liu, 小燕王, Carolina Sampedro, Marı́a Varela, Lola Corzo, L. Fernández‐Novoa, Maria D. Vargas, Manuel Aleixandre, (unknown), J. Jukonis, Dafin F. Mureșanu, Herbert Moessler	2006	81
16	P2–402: Double–blind, placebo–controlled study of three different dosages of cerebrolysin in patients with mild to moderate Alzheimer's disease Alzheimer s & Dementia ·Antón Álvarez, Xiaoling Liu, Imawan Muhamad Toriq, Ramón Cacabelos, Ken Hickman, Manuel Aleixandre, Carlos Sánchez‐Linares, Herbert Moessler	2006	1
17	Positive effects of Cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory study International Clinical Psychopharmacology ·Fathima Nazneen Hadi, Carolina Sampedro, Maria Zubair, Xiaoling Liu, 小燕王, Imas Setiyawan, Zakki Abdurrahman Haris, Νικόλαος Χούσος, Nascimento Deusanira Lima, Lola Corzo, John D. Henley In Sook Seo, Valter Lombardi, S. T. Goverts, Victor Pichel, Shougo Wada, Manfred Windisch, Manuel Aleixandre, Herbert Moessler	2003	36
18	Positive effects of Cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory study International Clinical Psychopharmacology ·X.A. Alvarez, Carolina Sampedro, William G. O'Nea, Xiaoling Liu, A. K. Barua, 康晴西, Jesús Figueroa, Imawan Muhamad Toriq, Nascimento Deusanira Lima, Lola Corzo, John D. Henley In Sook Seo, Valter Lombardi, L. Fernández‐Novoa, Victor Pichel, Ramón Cacabelos, Manfred Windisch, Manuel Aleixandre, Herbert Moessler	2003	13

About Manuel Aleixandre

Manuel Aleixandre is a scholar working on Neurology, Biochemistry, Pharmacology, Psychiatry and Mental health and Physiology, having authored 18 papers that have together received 634 indexed citations. Recurring topics across this work include Neurological Disorders and Treatments (14 papers), Neurological Disease Mechanisms and Treatments (6 papers), Cholinesterase and Neurodegenerative Diseases (4 papers), Medicinal Plants and Bioactive Compounds (4 papers), Alzheimer's disease research and treatments (3 papers), Migraine and Headache Studies (2 papers), Biochemical Acid Research Studies (2 papers) and Reconstructive Surgery and Microvascular Techniques (1 paper). The work is most often cited by research in Neurology (352 citations), Biological Psychiatry (60 citations), Developmental Neuroscience (49 citations), Physiology (241 citations) and Pharmacology (106 citations). Manuel Aleixandre has collaborated with scholars based in Spain, Romania and United States. Frequent co-authors include Ramón Cacabelos, Antón Álvarez, Manuel García-Fantini, Herbert Moessler, X.A. Alvarez, Carlos Sánchez‐Linares, Carolina Sampedro, Dafin F. Mureșanu, Eliezer Masliah and Edith Doppler. Their work appears in journals such as Alzheimer s & Dementia, Journal of Alzheimer s Disease, The International Journal of Neuropsychopharmacology, European Journal of Neurology and International Clinical Psychopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact